Trulance® Safety Indicated for adult patients with CIC and IBS-C. ISI available below.
Trulance Overview CIC Indication IBS-C Indication Patient Support HCP Resources Investors
Contact HCP Portal
Home/For Healthcare Professionals

HCP Resources

Clinical and access support for TRULANCE

Indication-specific materials, safety details, and reimbursement tools to support adult patients with CIC and IBS-C.

CIC materials IBS-C materials

Clinical essentials

Key prescribing considerations

Confirm adult status and absence of mechanical GI obstruction before initiating TRULANCE. Review safety, dosing, and counseling points with every prescription.

Indications

Treatment of adults with CIC and adults with IBS-C. Avoid use in pediatric patients; contraindicated in patients <6 years of age.

Dosing & Administration

Follow approved prescribing instructions. Counsel on potential for diarrhea; instruct patients to report severe diarrhea promptly.

Safety & Monitoring

Monitor for severe diarrhea. Review contraindications and reinforce reading of Important Safety Information.

Clinical data presentation

Evidence & access

Data and reimbursement support

  • Clinical trials demonstrating efficacy and safety are summarized for quick reference.
  • Payer and access resources to help navigate prior authorization.
  • Printable resources for patient counseling and ISI review.
See publications Clinical trial overview →
Questions on access or safety? Contact Synergy at +1 (276) 248-2886 or info@synergycures.com. For medical emergencies, direct patients to emergency services.